ALTHE — Theraclion SA Cashflow Statement
0.000.00%
Last trade - 00:00- €15.22m
- €12.34m
- €0.83m
Annual cashflow statement for Theraclion SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.91 | -3.76 | -4.96 | -3.68 | -5.76 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | 0.003 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.146 | -0.214 | -0.411 | -1.45 | 2.02 |
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.32 | -3.88 | -5.27 | -2.48 | -2.91 |
| Capital Expenditures | -0.132 | -0.148 | -0.323 | -0.112 | -0.102 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.061 | -0.376 | -0.417 | -0.101 | -0.086 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.193 | -0.524 | -0.74 | -0.214 | -0.188 |
| Financing Cash Flow Items | — | 0 | — | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.41 | 4.56 | 6.03 | 7.99 | -0.545 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.891 | 0.148 | 0.027 | 5.3 | -3.64 |